Literature DB >> 3733256

Differentiation antigens in fetal human pancreas. Reexpression in cancer.

M J Escribano, J Cordier, M Nap, F J Ten Kate, P Burtin.   

Abstract

An antiserum was raised against pancreatic extracts obtained from human fetuses under 5 months of gestational age. After absorption with adult tissues, this antiserum specifically recognized antigens located in the cytoplasm of fetal pancreatic acini. All of the examined pancreatic tissues, ranging from 3 to 5 months of gestational age, showed a strong positive reaction of most of the acinar cells. The number of stained acini and the staining intensity gradually decreased from 5 months onwards and by the 7th-8th month only a few cells remained positive. Adult pancreas was completely negative as were a variety of normal adult and fetal tissues. This antiserum also reacted with tumor structures in 18/18 pancreatic adenocarcinomas as well as with pancreatic acini in the vicinity of tumor. Primary carcinomas of the liver, large bowel, stomach, breast, urinary bladder, lung and other localizations did not react with this antiserum. In some cases of chronic pancreatitis (3/12) a reaction was observed in a few acinar cells. Immunoblot assay after polyacrylamide electrophoresis revealed, in both fetuses and tumors, two main antigens of approximately 60 kDa and 110 kDa relative molecular weight. Several minor components were also observed. These results suggest that our polyclonal antiserum defines a new group of oncodevelopmental antigens with high organ specificity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733256     DOI: 10.1002/ijc.2910380202

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein binds to membrane of human pancreatic tumoral SOJ-6 cells and inhibits the growth of tumor xenografts.

Authors:  Laurence Panicot-Dubois; Muriel Aubert; Cécile Franceschi; Eric Mas; Françoise Silvy; Christian Crotte; Jean-Paul Bernard; Dominique Lombardo; Marie-Odile Sadoulet
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

2.  Radioimmunolocalization of the monoclonal antibody J28 in early transformation stages in N-nitrosobis(2-hydroxypropyl)amine-induced pancreatic tumors in the Syrian golden hamster.

Authors:  Y Takeda; F Miralles; N Daher; M J Escribano
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2 O-glycans that can be modified by ABO blood group determinants.

Authors:  Khadija El Jellas; Bente B Johansson; Karianne Fjeld; Aristotelis Antonopoulos; Heike Immervoll; Man H Choi; Dag Hoem; Mark E Lowe; Dominique Lombardo; Pål R Njølstad; Anne Dell; Eric Mas; Stuart M Haslam; Anders Molven
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

4.  Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.

Authors:  D S Weinberg; B Ruggeri; M T Barber; S Biswas; S Miknyocki; S A Waldman
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  Human fetoacinar pancreatic protein: an oncofetal glycoform of the normally secreted pancreatic bile-salt-dependent lipase.

Authors:  E Mas; N Abouakil; S Roudani; F Miralles; O Guy-Crotte; C Figarella; M J Escribano; D Lombardo
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

6.  A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.

Authors:  Aurélie Collignon; Adriana Teodora Perles-Barbacaru; Stéphane Robert; Françoise Silvy; Emmanuelle Martinez; Isabelle Crenon; Sébastien Germain; Stéphane Garcia; Angèle Viola; Dominique Lombardo; Eric Mas; Evelyne Béraud
Journal:  Oncotarget       Date:  2015-09-15

7.  The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19/9.

Authors:  Y Fujii; G H Albers; A Carre-Llopis; M J Escribano
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

Review 8.  Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?

Authors:  Dominique Lombardo; Françoise Silvy; Isabelle Crenon; Emmanuelle Martinez; Aurélie Collignon; Evelyne Beraud; Eric Mas
Journal:  Oncotarget       Date:  2017-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.